Gallbladder carcinoma producing alpha-fetoprotein

Matthew St Laurent, Robert M. Esterl, Glenn A. Halff, K. Vincent Speeg

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Alpha-feto protein (AFP) is a clinically useful marker for hepatocellular carcinoma, hepatoblastoma, and nonseminomatous testicular tumors. Elevated serum AFP can also occur with tumors of the gastrointestinal tract, pancreas, lung, kidney, and urachus. Serum AFP can also be minimally elevated in nonmalignant conditions including acute and chronic hepatitis, cirrhosis, and pregnancy. Reports of gallbladder carcinoma that elaborate AFP are extremely rare, and almost all represent papillary carcinomas. Until now, there have been only two reports in the world literature that describe undifferentiated gallbladder carcinoma with elevated serum AFP. The authors present one case of undifferentiated gallbladder carcinoma and another case of poorly differentiated gallbladder carcinoma with increased serum AFP. In both cases, serum AFP was particularly useful in documenting metastatic recurrence of gallbladder carcinoma.

Original languageEnglish (US)
Pages (from-to)155-158
Number of pages4
JournalJournal of Clinical Gastroenterology
Issue number2
StatePublished - Mar 1999


  • AFP tumor marker
  • Undifferentiated gallbladder carcinoma

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Gallbladder carcinoma producing alpha-fetoprotein'. Together they form a unique fingerprint.

Cite this